RESUMEN
BACKGROUND: Cancer-related cognitive dysfunction (CRCD) is a major functional disorder in patients with cancer. This central nervous dysfunction is found in up to 60% of patients after tumour therapy, often significantly limits the quality of life, and significantly impedes participation in working life. For this reason, diagnosis and treatment of CRCD are of central importance. This narrative review is intended to provide an overview and support for practical clinical care with regard to diagnostics and therapeutic options. SUMMARY: In Germany, CRCD has received insufficient attention in clinical practice due to the lack of guidelines for diagnosis and therapy. The pathophysiology is complex and cannot be explained by chemotherapeutic treatment alone. In addition to the tumour disease as such and the tumour therapy, psychological factors such as anxiety and depression as well as sleep disorders also play a significant role. Today, it is known that in addition to age, molecular genetic changes also have an effect on cognitive function. Morphologically, CRCD can be located in the frontal cortex and hippocampus. In addition to easy-to-use screening instruments such as the visual analogue scale, validated questionnaires such as the Questionnaire of Subjectively Experienced Deficits in Attention (FEDA) developed in Germany are also available. These allow the suspected diagnosis to be substantiated and the patient to be referred to further neurological, neuropsychological, or psycho-oncological diagnostics. Within the framework of further neuropsychological diagnostics, the International Cognition and Cancer Task Force (ICCTF) recommends testing learning, memory, processing speed, and executive functions. From the authors' point of view, a step-by-step diagnosis is recommended in order to avoid overdiagnosis. In clinical practice, graduation according to the "Common Terminology Criteria for Adversity Events" (CTCAE Version 5.0) is suitable for assessing the degree of severity. Cognitive training should be behaviourally oriented and include regular practice of cognitive skills to restore attention, psychomotor speed, memory, and executive functions. The best evidence is currently found for web-based training programmes that can be used by the patient at home. There is also evidence for mindfulness training and physical exercises. In particular, the combination of these three therapeutic elements currently seems to be the optimal treatment strategy for CRCD. KEY MESSAGES: Cognitive dysfunction should be given much more attention in the clinical care of cancer patients. Diagnostic tools for this purpose and evidence-based therapeutic interventions are available. In the future, networks should be created that allow for better care of patients with CRCD.
Asunto(s)
Disfunción Cognitiva , Neoplasias , Humanos , Disfunción Cognitiva/diagnóstico , Disfunción Cognitiva/etiología , Disfunción Cognitiva/terapia , Neoplasias/complicaciones , Neoplasias/terapia , Neoplasias/psicología , Alemania , Calidad de Vida , Pruebas NeuropsicológicasRESUMEN
BACKGROUND: Diagnostics of Alzheimer's Disease (AD) require a multimodal approach. Neuropsychologists examine the degree and etiology of dementia syndromes and results are combined with those of cerebrospinal fluid markers and imaging data. In the diagnostic process, neuropsychologists often rely on anamnestic and clinical information, as well as cognitive tests, prior to the availability of exhaustive etiological information. The congruency of this phenomenological approach with results from FDG-PET/CT examinations remains to be explored. The latter yield highly accurate diagnostic information. METHOD: A mixed sample of N = 127 hospitalized neurological patients suspected of displaying a dementia syndrome underwent extensive neuropsychological and FDG-PET/CT examinations. Neuropsychological examinations included an anamnestic and clinical interview, and the CERAD cognitive test battery. Two decisional approaches were considered: First, routine diagnostic results were obtained, i.e. the final clinical decision of the examining neuropsychologist (ADClinical vs. non-ADClinical). Secondly, a logistic regression model was implemented, relying on CERAD profiles alone. CERAD subscales that best predicted AD based on FDG-PET/CT were identified and a nominal categorization obtained (ADTest vs. non-ADTest). Congruency of results from both approaches with those of the FDG-PET/CT (ADPET vs. non-ADPET) were estimated with Cohen's Kappa (κ) and Yule's Y coefficient of colligation. Descriptive estimates of accuracy, sensitivity and specificity of CERAD relative to FDG-PET/CT diagnostics were derived. RESULTS: ADPET patients constituted N = 33/127 (26%) of the sample. The clinical decision approach (ADClinical vs. non-ADClinical) showed substantial agreement with the FDG-PET/CT classification (κ = .69, Y = .72) involving good accuracy (84.2%), moderate sensitivity (75.8%) and excellent specificity (92.6%). In contrast, the decisional approach that relied on CERAD data alone (ADTest vs. non-ADTest) involved only moderate agreement with the FDG-PET/CT (κ = .54, Y = .62) with lower accuracy (74.8%), attributable to decreased sensitivity (56.3%) and comparable specificity (93.3%). CONCLUSIONS: It is feasible to identify AD through a comprehensive neuropsychological examination in a mixed sample of neurological patients. However, within the boundaries of methods applied here, decisions based on cognitive test results alone appear limited. One may conclude that the clinical impression based on anamnestic and clinical information obtained by the neuropsychological examiner plays a crucial role in the identification of AD patients in routine clinical practice.
Asunto(s)
Enfermedad de Alzheimer , Disfunción Cognitiva , Enfermedad de Alzheimer/líquido cefalorraquídeo , Enfermedad de Alzheimer/diagnóstico por imagen , Encéfalo/diagnóstico por imagen , Disfunción Cognitiva/diagnóstico , Fluorodesoxiglucosa F18 , Humanos , Tomografía Computarizada por Tomografía de Emisión de Positrones , Tomografía de Emisión de Positrones/métodosRESUMEN
The study was aimed at investigating the features of gnostic functions in the elderly people suffering from dementia. To implement the objectives of the study and to solve the set tasks, the following methods were used: visual gnosis tests (recognition of images, the selection of three subject pictures, selecting parts of a whole, etc.), the acoustic gnosis tests (score and perception of rhythms, recognition of nonspeech sounds), and tactile gnosis tests (tactile identification, Teuber test, Foerster test). When running the visual gnosis tests, the elderly people with the dementia diseases slowly initiated the tasks, made numerous errors, and sometimes could not cope with the tasks at all. Also, the perception integrity disorders, the presence of fragmentation, lack of accuracy, differentiation, preservation of specific objective images-objects, and the violation in the understanding of the spatial arrangement of things were revealed. When performing the auditory-motor coordination tests, the elderly people suffering from dementia needed more time to listen to, they asked for the repeated sound representation, and there were often errors in the rhythmic structure reproduction. When performing the tactile gnosis tests, the elderly people suffering from dementia had difficulties in identifying the subject by touch, in understanding the right and left-sided spatial relationships, and also made errors in recognizing one of the touches when the experimenter touched their hands. Based on the study results, the recommendations have been developed for the preservation and improvement of the existing gnostic functions' disorders in the elderly people suffering from dementia. The recommendations are complex, and they can also be useful for the medical staff whose professional activity is directly related to the elderly people suffering from dementia, their relatives and the persons closest to them.
Asunto(s)
Humanos , Anciano , Anciano de 80 o más Años , Reconocimiento Visual de Modelos , Prueba de Secuencia Alfanumérica , Acústica , Cognición , Trastornos del Conocimiento/terapia , Demencia/patología , Agnosia/patologíaRESUMEN
OBJECTIVE: Parkinson's disease with mild cognitive impairment (PD-MCI) is a risk factor for progression to PD dementia (PDD) at a later stage of the disease. The consensus criteria of PD-MCI use a traditional test-by-test normative comparison. The aim of this study was to investigate whether a new multivariate statistical method provides a more sensitive tool for predicting dementia status at 3- and 5-year follow-ups. This method allows a formal evaluation of a patient's profile of test scores given a large aggregated database with regression-based norms. METHOD: The cognitive test results of 123 newly diagnosed PD patients from a previously published longitudinal study were analyzed with three different methods. First, the PD-MCI criteria were applied in the traditional way. Second, the PD-MCI criteria were applied using the large aggregated normative database. Last, multivariate normative comparisons (MNCs) were made using the same aggregated normative database. The outcome variable was progression to dementia within 3 and 5 years. RESULTS: The MNC was characterized by higher sensitivity and higher specificity in predicting progression to PDD at follow-up than the two PD-MCI criteria methods, although the difference in classification accuracy did not reach statistical significance. CONCLUSION: We conclude that MNCs could allow for a more accurate prediction of PDD than the traditional PD-MCI criteria, because there are encouraging trends in both increased sensitivity and increased specificity. (JINS, 2019, 25, 678-687).
Asunto(s)
Disfunción Cognitiva/etiología , Demencia/diagnóstico , Demencia/etiología , Progresión de la Enfermedad , Enfermedad de Parkinson/complicaciones , Anciano , Interpretación Estadística de Datos , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Sensibilidad y EspecificidadRESUMEN
BACKGROUND: One of the first symptoms of Alzheimer's disease (AD) is word retrieval deficits. A systematic evaluation of word retrieval deficits can have an important predictive value for developing Alzheimer's disease. OBJECTIVE: Is the test for finding word retrieval deficits (word findingâ¯= WoFi) able to detect deficits in word retrieval and does it correlate with other dementia tests? METHODS: A word retrieval test called WoFi was developed. It is an instrument that tests word retrieval deficits based on 50 questions. A maximum of 100 points can be scored. RESULTS: The control group scored significantly better than the AD group. Using a cut-off score of 84 points WoFi could discriminate controls from subjects with a sensitivity of 95% and a specificity of 92%. CONCLUSION: The use of WoFi was able to test for word retrieval deficits. Application required less than 15â¯min and test instructions are very simple. This instrument might be useful in telehealth.